Knowledge Base

Optimizing Successful Development of Viral Vector Gene Therapies, Gene Therapy Trials, and Companion Diagnostics Precision Xtract December 5, 2019

Explore general principles to optimize the likelihood of preclinical and clinical trial development success, and provide a more specific focus on considerations for AAV based gene therapies. Read More

The Role of Integrated Scientific Advice for the Early Determination of RWE Requirements in HTA and Payer Assessments Evidera, Inc. December 3, 2019

Read our white paper to learn how Integrated Scientific Advice can refine and evaluate evidence generation plans to align with regulatory and HTA needs. Read More

Pragmatic Randomized Trials: Considerations for Design and Implementation Evidera, Inc. November 20, 2019

The use of pragmatic randomized trials (PRTs) can answer if a treatment is safe and effective. Learn how PRTs can collect RWE to meet regulator and payer needs in our recent white paper. Read More

Delivering on the Promise of Cell Therapy: Challenges and Trends Precision Xtract November 20, 2019

Explore the current landscape of cell therapy (e.g. CAR-T), highlighting challenges and opportunities sponsors face as they endeavor to translate these treatments from the bench to the bedside. Read More

What Do Value Assessments Miss? Precision Xtract November 14, 2019

Understand key drivers of the value conversation and how the definition of value goes beyond quality & cost of care to include other dimensions that should be factored into developing value frameworks Read More

Insights from the NICE 2019 Annual Conference on Transforming Care Evidera, Inc. June 25, 2019

Evidera had several representatives in attendance at NICE's Annual Conference to garner insight into their perspective on improving access to innovative treatments and what it means for our clients. Read More

Situation Analysis and Opportunity Assessment New Perspectives, Inc. March 11, 2019

A successful product development strategy requires a comprehensive understanding of the market environment. Learn more… Read More

Conducting Feasibility for a New Clinical Trial April 10, 2018 in White Papers,

What does the word “feasibility” mean to you? It may seem like a simple question, but I have found that “feasibility” has many interpretations within the clinical research industry. When we work with Read More